Mitochondria and Cancer

Cell

Volumn 166, Issue 3, 2016, Pages 555-566

  Vyas, Sejal ^a   Zaganjor, Elma ^a   Haigis, Marcia C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; MITOCHONDRIAL DNA; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR;

ADAPTATION; AMINO ACID METABOLISM; BIOENERGY; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL GROWTH; CELL METABOLISM; CELL SURVIVAL; GENE MUTATION; GLUCOSE UTILIZATION; HUMAN; IN VIVO STUDY; INTRACELLULAR SIGNALING; LIPID METABOLISM; METASTASIS; METASTASIS POTENTIAL; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MITOPHAGY; NEOPLASM; NONHUMAN; NUCLEAR REPROGRAMMING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; TURNOVER TIME; ANIMAL; PHYSIOLOGY;

ANIMALS; CARCINOGENESIS; HUMANS; MITOCHONDRIA;

EID: 84979503588     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.07.002     Document Type: Review

References (101)

1. Adam, J., Hatipoglu, E., O'Flaherty, L., Ternette, N., Sahgal, N., Lockstone, H., Baban, D., Nye, E., Stamp, G.W., Wolhuter, K., et al. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20 (2011), 524–537.
2. Aisenberg, A.C., Reinafarje, B., Potter, V.R., Studies on the Pasteur effect. I. General observations. J. Biol. Chem. 224 (1957), 1099–1113.
3. Bause, A.S., Haigis, M.C., SIRT3 regulation of mitochondrial oxidative stress. Exp. Gerontol. 48 (2013), 634–639.
4. Bell, E.L., Emerling, B.M., Ricoult, S.J., Guarente, L., SirT3 suppresses hypoxia inducible factor 1α and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30 (2011), 2986–2996.
5. Ben-Sahra, I., Hoxhaj, G., Ricoult, S.J., Asara, J.M., Manning, B.D., mTORC1 induces purine synthesis through control of the mitochondrial tetrahydrofolate cycle. Science 351 (2016), 728–733.
6. Berkers, C.R., Maddocks, O.D., Cheung, E.C., Mor, I., Vousden, K.H., Metabolic regulation by p53 family members. Cell Metab. 18 (2013), 617–633.
7. Birsoy, K., Wang, T., Chen, W.W., Freinkman, E., Abu-Remaileh, M., Sabatini, D.M., An Essential Role of the Mitochondrial Electron Transport Chain in Cell Proliferation Is to Enable Aspartate Synthesis. Cell 162 (2015), 540–551.
8. Carey, B.W., Finley, L.W., Cross, J.R., Allis, C.D., Thompson, C.B., Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature 518 (2015), 413–416.
9. Carracedo, A., Cantley, L.C., Pandolfi, P.P., Cancer metabolism: fatty acid oxidation in the limelight. Nat. Rev. Cancer 13 (2013), 227–232.
10. Chourasia, A.H., Boland, M.L., Macleod, K.F., Mitophagy and cancer. Cancer Metab., 3, 2015, 4.
11. Christofk, H.R., Vander Heiden, M.G., Harris, M.H., Ramanathan, A., Gerszten, R.E., Wei, R., Fleming, M.D., Schreiber, S.L., Cantley, L.C., The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452 (2008), 230–233.
12. Coloff, J.L., Murphy, J.P., Braun, C.R., Harris, I.S., Shelton, L.M., Kami, K., Gygi, S.P., Selfors, L.M., Brugge, J.S., Differential Glutamate Metabolism in Proliferating and Quiescent Mammary Epithelial Cells. Cell Metab. 23 (2016), 867–880.
13. Csibi, A., Fendt, S.M., Li, C., Poulogiannis, G., Choo, A.Y., Chapski, D.J., Jeong, S.M., Dempsey, J.M., Parkhitko, A., Morrison, T., et al. The mTORC1 pathway stimulates glutamine metabolism and cell proliferation by repressing SIRT4. Cell 153 (2013), 840–854.
14. Currie, E., Schulze, A., Zechner, R., Walther, T.C., Farese, R.V. Jr., Cellular fatty acid metabolism and cancer. Cell Metab. 18 (2013), 153–161.
15. Dang, C.V., Kim, J.W., Gao, P., Yustein, J., The interplay between MYC and HIF in cancer. Nat. Rev. Cancer 8 (2008), 51–56.
16. Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462 (2009), 739–744.
17. Davidson, S.M., Papagiannakopoulos, T., Olenchock, B.A., Heyman, J.E., Keibler, M.A., Luengo, A., Bauer, M.R., Jha, A.K., O'Brien, J.P., Pierce, K.A., et al. Environment Impacts the Metabolic Dependencies of Ras-Driven Non-Small Cell Lung Cancer. Cell Metab. 23 (2016), 517–528.
18. De Luca, A., Fiorillo, M., Peiris-Pagès, M., Ozsvari, B., Smith, D.L., Sanchez-Alvarez, R., Martinez-Outschoorn, U.E., Cappello, A.R., Pezzi, V., Lisanti, M.P., Sotgia, F., Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells. Oncotarget 6 (2015), 14777–14795.
19. DeBerardinis, R.J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., Thompson, C.B., Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. USA 104 (2007), 19345–19350.
20. DeNicola, G.M., Karreth, F.A., Humpton, T.J., Gopinathan, A., Wei, C., Frese, K., Mangal, D., Yu, K.H., Yeo, C.J., Calhoun, E.S., et al. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis. Nature 475 (2011), 106–109.
21. Dibble, C.C., Cantley, L.C., Regulation of mTORC1 by PI3K signaling. Trends Cell Biol. 25 (2015), 545–555.
22. Ducker, G.S., Chen, L., Morscher, R.J., Ghergurovich, J.M., Esposito, M., Teng, X., Kang, Y., Rabinowitz, J.D., Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway. Cell Metab. 23 (2016), 1140–1153.
23. Ernster, L., Schatz, G., Mitochondria: a historical review. J. Cell Biol. 91 (1981), 227s–255s.
24. Faubert, B., Vincent, E.E., Poffenberger, M.C., Jones, R.G., The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator. Cancer Lett. 356:2 Pt A (2015), 165–170.
25. Finley, L.W., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P.I., Cardoso, S.M., Clish, C.B., et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell 19 (2011), 416–428.
26. German, N.J., Haigis, M.C., Sirtuins and the Metabolic Hurdles in Cancer. Curr. Biol. 25 (2015), R569–R583.
27. Ghosh, J.C., Siegelin, M.D., Vaira, V., Faversani, A., Tavecchio, M., Chae, Y.C., Lisanti, S., Rampini, P., Giroda, M., Caino, M.C., et al. Adaptive mitochondrial reprogramming and resistance to PI3K therapy. J. Natl. Cancer Inst., 107, 2015, dju502.
28. Gopal, Y.N., Rizos, H., Chen, G., Deng, W., Frederick, D.T., Cooper, Z.A., Scolyer, R.A., Pupo, G., Komurov, K., Sehgal, V., et al. Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma. Cancer Res. 74 (2014), 7037–7047.
29. Graves, J.A., Wang, Y., Sims-Lucas, S., Cherok, E., Rothermund, K., Branca, M.F., Elster, J., Beer-Stolz, D., Van Houten, B., Vockley, J., Prochownik, E.V., Mitochondrial structure, function and dynamics are temporally controlled by c-Myc. PLoS ONE, 7, 2012, e37699.
30. Guo, J.Y., Chen, H.Y., Mathew, R., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., Kamphorst, J.J., Chen, G., Lemons, J.M., Karantza, V., et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 25 (2011), 460–470.
31. Guo, J.Y., Karsli-Uzunbas, G., Mathew, R., Aisner, S.C., Kamphorst, J.J., Strohecker, A.M., Chen, G., Price, S., Lu, W., Teng, X., et al. Autophagy suppresses progression of K-ras-induced lung tumors to oncocytomas and maintains lipid homeostasis. Genes Dev. 27 (2013), 1447–1461.
32. Haq, R., Shoag, J., Andreu-Perez, P., Yokoyama, S., Edelman, H., Rowe, G.C., Frederick, D.T., Hurley, A.D., Nellore, A., Kung, A.L., et al. Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. Cancer Cell 23 (2013), 302–315.
33. Harris, I.S., Treloar, A.E., Inoue, S., Sasaki, M., Gorrini, C., Lee, K.C., Yung, K.Y., Brenner, D., Knobbe-Thomsen, C.B., Cox, M.A., et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 27 (2015), 211–222.
34. Hu, Y.L., DeLay, M., Jahangiri, A., Molinaro, A.M., Rose, S.D., Carbonell, W.S., Aghi, M.K., Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma. Cancer Res. 72 (2012), 1773–1783.
35. Jain, M., Nilsson, R., Sharma, S., Madhusudhan, N., Kitami, T., Souza, A.L., Kafri, R., Kirschner, M.W., Clish, C.B., Mootha, V.K., Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336 (2012), 1040–1044.
36. Jeong, S.M., Lee, A., Lee, J., Haigis, M.C., SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma. J. Biol. Chem. 289 (2014), 4135–4144.
37. Jiang, D., LaGory, E.L., Kenzelmann Brož, D., Bieging, K.T., Brady, C.A., Link, N., Abrams, J.M., Giaccia, A.J., Attardi, L.D., Analysis of p53 transactivation domain mutants reveals Acad11 as a metabolic target important for p53 pro-survival function. Cell Rep. 10 (2015), 1096–1109.
38. Jiang, L., Shestov, A.A., Swain, P., Yang, C., Parker, S.J., Wang, Q.A., Terada, L.S., Adams, N.D., McCabe, M.T., Pietrak, B., et al. Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532 (2016), 255–258.
39. Jin, L., Li, D., Alesi, G.N., Fan, J., Kang, H.B., Lu, Z., Boggon, T.J., Jin, P., Yi, H., Wright, E.R., et al. Glutamate dehydrogenase 1 signals through antioxidant glutathione peroxidase 1 to regulate redox homeostasis and tumor growth. Cancer Cell 27 (2015), 257–270.
40. Kasahara, A., Scorrano, L., Mitochondria: from cell death executioners to regulators of cell differentiation. Trends Cell Biol. 24 (2014), 761–770.
41. Kashatus, J.A., Nascimento, A., Myers, L.J., Sher, A., Byrne, F.L., Hoehn, K.L., Counter, C.M., Kashatus, D.F., Erk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth. Mol. Cell 57 (2015), 537–551.
42. Kim, D., Fiske, B.P., Birsoy, K., Freinkman, E., Kami, K., Possemato, R.L., Chudnovsky, Y., Pacold, M.E., Chen, W.W., Cantor, J.R., et al. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature 520 (2015), 363–367.
43. Koivunen, P., Lee, S., Duncan, C.G., Lopez, G., Lu, G., Ramkissoon, S., Losman, J.A., Joensuu, P., Bergmann, U., Gross, S., et al. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483 (2012), 484–488.
44. LaGory, E.L., Wu, C., Taniguchi, C.M., Ding, C.K., Chi, J.T., von Eyben, R., Scott, D.A., Richardson, A.D., Giaccia, A.J., Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma. Cell Rep. 12 (2015), 116–127.
45. Lamb, R., Harrison, H., Hulit, J., Smith, D.L., Lisanti, M.P., Sotgia, F., Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget 5 (2014), 11029–11037.
46. Le, A., Lane, A.N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C.J., Slusher, B.S., Zhang, H., et al. Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15 (2012), 110–121.
47. Le Gal, K., Ibrahim, M.X., Wiel, C., Sayin, V.I., Akula, M.K., Karlsson, C., Dalin, M.G., Akyürek, L.M., Lindahl, P., Nilsson, J., Bergo, M.O., Antioxidants can increase melanoma metastasis in mice. Sci. Transl. Med., 7, 2015, 308re8.
48. LeBleu, V.S., O'Connell, J.T., Gonzalez Herrera, K.N., Wikman, H., Pantel, K., Haigis, M.C., de Carvalho, F.M., Damascena, A., Domingos Chinen, L.T., Rocha, R.M., Asara, J.M., Kalluri, R., Pgc-1alpha Mediates Mitochondrial Biogenesis and Oxidative Phosphorylation in Cancer Cells to Promote Metastasis. Nat. Cell. Biol. 16 (2014), 992–1003 1001–1015.
49. Lee, J.V., Carrer, A., Shah, S., Snyder, N.W., Wei, S., Venneti, S., Worth, A.J., Yuan, Z.F., Lim, H.W., Liu, S., et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metab. 20 (2014), 306–319.
50. Li, F., Wang, Y., Zeller, K.I., Potter, J.J., Wonsey, D.R., O'Donnell, K.A., Kim, J.W., Yustein, J.T., Lee, L.A., Dang, C.V., Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol. Cell. Biol. 25 (2005), 6225–6234.
51. Li, X., Jiang, Y., Meisenhelder, J., Yang, W., Hawke, D.H., Zheng, Y., Xia, Y., Aldape, K., He, J., Hunter, T., et al. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. Mol. Cell 61 (2016), 705–719.
52. Lopez, J., Tait, S.W., Mitochondrial apoptosis: killing cancer using the enemy within. Br. J. Cancer 112 (2015), 957–962.
53. Losman, J.A., Looper, R.E., Koivunen, P., Lee, S., Schneider, R.K., McMahon, C., Cowley, G.S., Root, D.E., Ebert, B.L., Kaelin, W.G. Jr., (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible. Science 339 (2013), 1621–1625.
54. Lu, C., Ward, P.S., Kapoor, G.S., Rohle, D., Turcan, S., Abdel-Wahab, O., Edwards, C.R., Khanin, R., Figueroa, M.E., Melnick, A., et al. IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature 483 (2012), 474–478.
55. MacKenzie, E.D., Selak, M.A., Tennant, D.A., Payne, L.J., Crosby, S., Frederiksen, C.M., Watson, D.G., Gottlieb, E., Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol. Cell. Biol. 27 (2007), 3282–3289.
56. Mancias, J.D., Kimmelman, A.C., Mechanisms of Selective Autophagy in Normal Physiology and Cancer. J. Mol. Biol. 428:9 Pt A (2016), 1659–1680.
57. Martinou, J.C., Youle, R.J., Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev. Cell 21 (2011), 92–101.
58. Matsuda, S., Nakanishi, A., Minami, A., Wada, Y., Kitagishi, Y., Functions and characteristics of PINK1 and Parkin in cancer. Front. Biosci. (Landmark Ed.) 20 (2015), 491–501.
59. Mishra, P., Chan, D.C., Metabolic regulation of mitochondrial dynamics. J. Cell Biol. 212 (2016), 379–387.
60. Morita, M., Gravel, S.P., Hulea, L., Larsson, O., Pollak, M., St-Pierre, J., Topisirovic, I., mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle 14 (2015), 473–480.
61. Mucaj, V., Shay, J.E., Simon, M.C., Effects of hypoxia and HIFs on cancer metabolism. Int. J. Hematol. 95 (2012), 464–470.
62. Mullen, A.R., Wheaton, W.W., Jin, E.S., Chen, P.H., Sullivan, L.B., Cheng, T., Yang, Y., Linehan, W.M., Chandel, N.S., DeBerardinis, R.J., Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481 (2011), 385–388.
63. Nikiforov, M.A., Chandriani, S., O'Connell, B., Petrenko, O., Kotenko, I., Beavis, A., Sedivy, J.M., Cole, M.D., A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism. Mol. Cell. Biol. 22 (2002), 5793–5800.
64. Nilsson, R., Jain, M., Madhusudhan, N., Sheppard, N.G., Strittmatter, L., Kampf, C., Huang, J., Asplund, A., Mootha, V.K., Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer. Nat. Commun., 5, 2014, 3128.
65. Nowicki, S., Gottlieb, E., Oncometabolites: tailoring our genes. FEBS J. 282 (2015), 2796–2805.
66. Papa, A., Wan, L., Bonora, M., Salmena, L., Song, M.S., Hobbs, R.M., Lunardi, A., Webster, K., Ng, C., Newton, R.H., et al. Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function. Cell 157 (2014), 595–610.
67. Pavlova, N.N., Thompson, C.B., The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 23 (2016), 27–47.
68. Piskounova, E., Agathocleous, M., Murphy, M.M., Hu, Z., Huddlestun, S.E., Zhao, Z., Leitch, A.M., Johnson, T.M., DeBerardinis, R.J., Morrison, S.J., Oxidative stress inhibits distant metastasis by human melanoma cells. Nature 527 (2015), 186–191.
69. Porporato, P.E., Payen, V.L., Pérez-Escuredo, J., De Saedeleer, C.J., Danhier, P., Copetti, T., Dhup, S., Tardy, M., Vazeille, T., Bouzin, C., et al. A mitochondrial switch promotes tumor metastasis. Cell Rep. 8 (2014), 754–766.
70. Pyakurel, A., Savoia, C., Hess, D., Scorrano, L., Extracellular regulated kinase phosphorylates mitofusin 1 to control mitochondrial morphology and apoptosis. Mol. Cell 58 (2015), 244–254.
71. Pylayeva-Gupta, Y., Grabocka, E., Bar-Sagi, D., RAS oncogenes: weaving a tumorigenic web. Nat. Rev. Cancer 11 (2011), 761–774.
72. Renault, T.T., Floros, K.V., Elkholi, R., Corrigan, K.A., Kushnareva, Y., Wieder, S.Y., Lindtner, C., Serasinghe, M.N., Asciolla, J.J., Buettner, C., et al. Mitochondrial shape governs BAX-induced membrane permeabilization and apoptosis. Mol. Cell 57 (2015), 69–82.
73. Reznik, E., Miller, M.L., Senbabaoglu, Y., Riaz, N., Sarungbam, J., Tickoo, S.K., Al-Ahmadie, H.A., Lee, W., Seshan, V.E., Hakimi, A.A., Sander, C., Mitochondrial DNA Copy Number Variation across Human Cancers. Elife, 5, 2016, e10769.
74. Sancho, P., Burgos-Ramos, E., Tavera, A., Bou Kheir, T., Jagust, P., Schoenhals, M., Barneda, D., Sellers, K., Campos-Olivas, R., Graña, O., et al. MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells. Cell Metab. 22 (2015), 590–605.
75. Sarosiek, K.A., Chi, X., Bachman, J.A., Sims, J.J., Montero, J., Patel, L., Flanagan, A., Andrews, D.W., Sorger, P., Letai, A., BID preferentially activates BAK while BIM preferentially activates BAX, affecting chemotherapy response. Mol. Cell 51 (2013), 751–765.
76. Schell, J.C., Olson, K.A., Jiang, L., Hawkins, A.J., Van Vranken, J.G., Xie, J., Egnatchik, R.A., Earl, E.G., DeBerardinis, R.J., Rutter, J., A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol. Cell 56 (2014), 400–413.
77. Senft, D., Ronai, Z.A., Regulators of mitochondrial dynamics in cancer. Curr. Opin. Cell Biol. 39 (2016), 43–52.
78. Serasinghe, M.N., Wieder, S.Y., Renault, T.T., Elkholi, R., Asciolla, J.J., Yao, J.L., Jabado, O., Hoehn, K., Kageyama, Y., Sesaki, H., Chipuk, J.E., Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors. Mol. Cell 57 (2015), 521–536.
79. Shadel, G.S., Horvath, T.L., Mitochondrial ROS signaling in organismal homeostasis. Cell 163 (2015), 560–569.
80. Son, J., Lyssiotis, C.A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R.M., Ferrone, C.R., Mullarky, E., Shyh-Chang, N., Kang, Y., Fleming, J.B., Bardeesy, N., Asara, J.M., Haigis, M.C., DePinho, R.A., Cantley, L.C., Kimmelman, A.C., Glutamine Supports Pancreatic Cancer Growth through a Kras-Regulated Metabolic Pathway. Nature 496 (2013), 101–105.
81. Stine, Z.E., Walton, Z.E., Altman, B.J., Hsieh, A.L., Dang, C.V., MYC, Metabolism, and Cancer. Cancer Discov. 5 (2015), 1024–1039.
82. Sullivan, L.B., Chandel, N.S., Mitochondrial reactive oxygen species and cancer. Cancer Metab., 2, 2014, 17.
83. Sullivan, L.B., Martinez-Garcia, E., Nguyen, H., Mullen, A.R., Dufour, E., Sudarshan, S., Licht, J.D., Deberardinis, R.J., Chandel, N.S., The proto-oncometabolite fumarate binds glutathione to amplify ROS-dependent signaling. Mol. Cell 51 (2013), 236–248.
84. Sullivan, L.B., Gui, D.Y., Hosios, A.M., Bush, L.N., Freinkman, E., Vander Heiden, M.G., Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating Cells. Cell 162 (2015), 552–563.
85. Tan, Z., Luo, X., Xiao, L., Tang, M., Bode, A.M., Dong, Z., Cao, Y., The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications. Mol. Cancer Ther. 15 (2016), 774–782.
86. Tardito, S., Oudin, A., Ahmed, S.U., Fack, F., Keunen, O., Zheng, L., Miletic, H., Sakariassen, P.O., Weinstock, A., Wagner, A., et al. Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma. Nat. Cell Biol. 17 (2015), 1556–1568.
87. Toyama, E.Q., Herzig, S., Courchet, J., Lewis, T.L. Jr., Losón, O.C., Hellberg, K., Young, N.P., Chen, H., Polleux, F., Chan, D.C., Shaw, R.J., Metabolism. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress. Science 351 (2016), 275–281.
88. Vacanti, N.M., Divakaruni, A.S., Green, C.R., Parker, S.J., Henry, R.R., Ciaraldi, T.P., Murphy, A.N., Metallo, C.M., Regulation of substrate utilization by the mitochondrial pyruvate carrier. Mol. Cell 56 (2014), 425–435.
89. van Gisbergen, M.W., Voets, A.M., Starmans, M.H., de Coo, I.F., Yadak, R., Hoffmann, R.F., Boutros, P.C., Smeets, H.J., Dubois, L., Lambin, P., How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat. Res. Rev. Mutat. Res. 764 (2015), 16–30.
90. Vaseva, A.V., Moll, U.M., The mitochondrial p53 pathway. Biochim. Biophys. Acta 1787 (2009), 414–420.
91. Viale, A., Pettazzoni, P., Lyssiotis, C.A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Nature 514 (2014), 628–632.
92. von Eyss, B., Jaenicke, L.A., Kortlever, R.M., Royla, N., Wiese, K.E., Letschert, S., McDuffus, L.A., Sauer, M., Rosenwald, A., Evan, G.I., et al. A MYC-Driven Change in Mitochondrial Dynamics Limits YAP/TAZ Function in Mammary Epithelial Cells and Breast Cancer. Cancer Cell 28 (2015), 743–757.
93. Vyas, S., Chang, P., New PARP targets for cancer therapy. Nat. Rev. Cancer 14 (2014), 502–509.
94. Wang, P., Song, M., Zeng, Z.L., Zhu, C.F., Lu, W.H., Yang, J., Ma, M.Z., Huang, A.M., Hu, Y., Huang, P., Identification of NDUFAF1 in mediating K-Ras induced mitochondrial dysfunction by a proteomic screening approach. Oncotarget 6 (2015), 3947–3962.
95. Warburg, O., On the origin of cancer cells. Science 123 (1956), 309–314.
96. Ward, P.S., Patel, J., Wise, D.R., Abdel-Wahab, O., Bennett, B.D., Coller, H.A., Cross, J.R., Fantin, V.R., Hedvat, C.V., Perl, A.E., et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17 (2010), 225–234.
97. Weinhouse, S., On respiratory impairment in cancer cells. Science 124 (1956), 267–269.
98. Wellen, K.E., Hatzivassiliou, G., Sachdeva, U.M., Bui, T.V., Cross, J.R., Thompson, C.B., ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324 (2009), 1076–1080.
99. Yang, C., Ko, B., Hensley, C.T., Jiang, L., Wasti, A.T., Kim, J., Sudderth, J., Calvaruso, M.A., Lumata, L., Mitsche, M., et al. Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport. Mol. Cell 56 (2014), 414–424.
100. Ye, J., Fan, J., Venneti, S., Wan, Y.W., Pawel, B.R., Zhang, J., Finley, L.W., Lu, C., Lindsten, T., Cross, J.R., et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discov. 4 (2014), 1406–1417.
101. Zhang, H., Gao, P., Fukuda, R., Kumar, G., Krishnamachary, B., Zeller, K.I., Dang, C.V., Semenza, G.L., HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of C-MYC activity. Cancer Cell 11 (2007), 407–420.